Gapping up
In reaction to earnings/guidance:
- MDRX +8.6% (issues upside Q4 rev guidance, also approves new $250 mln share repurchase program), ERIC +5.6%, CFB +4.8%, IBTX +4.5%, LOGI +4.2%, CUBI +1.8%, IBM +1.5%, AXP +1.2%, MMM +1.1%, IPAR +1% (guides Q4 revs above consensus; guides FY22 earnings and revs above consensus), VZ +1%, LMT +0.8%, IVZ +0.7%, BRO +0.6%, ADM +0.6%
Other news:
- SRRA +66.3% (announces that momelotinib achieved "statistically significant" efficacy across key endpoints; also updates on the financial support for momelotinib)
- SDC +6% (announces series of strategic actions including reduction of workforce; reaffirms FY21 rev guidance)
- HLGN +3.8% (stock offering)
- CPLP +2.9% (increases dividend)
- EFTR +2.7% (provides pipeline updates; establishes investment agreement with Lincoln Park Capital)
- DCPH +2.5% (presents results from the INTRIGUE Phase 3 study)
- SILV +2.3% (Las Chispas Construction Update - Tracking Ahead of Schedule and On Budget)
- SON +2.2% (to increase prices for all paperboard tubes and cores)
- VST +1.5% (confirms planned expansion of Moss Landing Energy Storage Facility)
Analyst comments:
- BPMC +2.4% (upgraded to Buy from Hold at Stifel)
- NKE +0.5% (upgraded to Overweight from Equal Weight at Wells Fargo)